Thromboembolic events in beta thalassemia major: An Italian multicenter study

Acta Haematologica

Volumn 99, Issue 2, 1998, Pages 76-79

  Borgna Pignatti, C ^a   Carnelli, V ^b   Caruso, V ^c   Dore, F ^d   De Mattia, D ^e   Di Palma, A ^f   Di Gregorio, F ^c   Romeo, M A ^c   Longhi, R ^b   Mangiagli, A ^g   Melevendi, C ^h   Pizzarelli, G ^c   Musumeci, S ^c,d  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

^d UNIVERSITY OF SASSARI   (Italy)

^e UNIVERSITY OF BARI   (Italy)

^f UNIVERSITY OF FERRARA   (Italy)

^g Department of Pediatrics   (Italy)

^h UNIVERSITY OF GENOA   (Italy)

Author keywords

Thalassemia; Thromboembolic events

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BETA THALASSEMIA; CARDIOMYOPATHY; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; FEMALE; HEADACHE; HEMIPARESIS; HUMAN; HYPOTHYROIDISM; INTRACARDIAC THROMBOSIS; LIVER DISEASE; LUNG EMBOLISM; MALE; MESENTERIC ARTERY; PATIENT MONITORING; PORTAL VEIN; PREGNANCY; PRIORITY JOURNAL; SEIZURE; THALASSEMIA MAJOR; THROMBOEMBOLISM;

ADOLESCENT; ADULT; BETA-THALASSEMIA; BLOOD COAGULATION; CHILD; FEMALE; HUMANS; INFANT, NEWBORN; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; THROMBOEMBOLISM;

EID: 0031930888     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000040814     Document Type: Article

References (22)

1. Zurlo MG, De Stefano P, Borgna Pignatti C, Di Palma A, Piga A, Melevendi C, Di Gregorio F, Burattini MG, Terzoli S: Survival and cause of death in thalassemia major. Lancet 1989;i:27-30.
2. Michaeli J, Mittelman M, Grisaru D, Rachmilewitz EA: Thromboembolic complications in beta thalassemia major. Acta Haematol 1992; 87:71-74.
3. Musumeci S, Longinotti M, Di Gregorio F, De Mattia D, Melevendi C, Carnelli V, Borgna Pignatti C: Il rischio trombotico nella beta talassemia major. XXXIII Congresso della Società Italiana di Ematologia, Verona, Giugno 23-26, 1991.
4. Eldor A: Abnormal platelet function in beta thalassemia. Scand J Haematol 1978;20:447-452.
5. Eldor A, Krausz Y, Atlan H, Snyder D, Goldfarb A, Hy-Am E, Rachmilewitz EA, Kotze HF, Heyns AP: Platelet survival in patients with beta-thalassemia. Am J Hematol 1989;32: 94-99.
6. Eldor A, Lellouche F, Goldfarb A, Maclouf J: In vivo platelet-activation in beta thalassemia major reflected by increased platelet thromboxane-urinary metabolites. Blood 1991;77:1749-1753.
7. Del Principe D, Menichelli AL, Di Giulio S, De Matteis W, Cianciulli P, Papa G: PADGEM/ GMP-140 expression on platelet membrane from homozygous beta-thalassemia patients. Br J Haematol 1993;84:111-117.
8. Cao A, Gabutti V, Masera G, Modell B, Sirchia G, Vullo C: Raccomandazioni per il trattamento della β talassemia. Saronno, Ciba-Geigy, 1990.
9. Di Gregorio F, Francario E, Romeo MA, Fichera A, Grasso L, Musumeci S: Complicanze neurologiche in soggetti con beta-talassemia major dopo multiple trasfusioni di sangue. Riv Pediatr Sicil 1983;3:153-163.
10. Sinniah HD, Vinguaedra V, Kamaruddin A: Neurological complication of beta-thalassemia major. Arch Dis Child 1977;52:977-979.
11. Wasi P, Nakorn S, Pootrakul P, Sonakul D, Piankijgum A, Pacharee P: A syndrome of hypertension, convulsion and cerebral hemorrhage in thalassaemic patients after blood transfusions. Lancet 1978;ii:602-604.
12. Wasi P, Fucharoen S, Winichagoon P: Hypoxemia in thalassemia. Int Symp Recent Adv Thalassaemia, Cagliari, June 7-11, 1981, p 21.
13. Cianciulli P, Trua G, Gaviano E, Papa G, Menichelli A, Di Giulio S, De Matteis W, Del Principe D: Platelet activation in thalassemic children. Pediatr Res 1991;30:646.
14. Schettini F, De Mattia D, Arcamone G, et al: Coagulation contact phase factors and inhibitors in beta-thalassemia major children. Pediatr Hematol Oncol 1987;4:231-236.
15. Musumeci S, Leonardi S, Di Dio R, Fischer A, Di Costa G: Protein C and antithrombin III in polytransfused thalassemic patients. Acta Haematol 1987;77:30-33.
16. Eldor E, Maclouf J, Durst R, Godefray C, Hy-Am E, Abramov A, Goldfarb A, Rachmilewitz EA, Ben Yashar V, Barenholz Y, de Raucourt E, Guillin MC: A chronic hypercoagulable state in beta-thalassemia major exists already in childhood and may be induced by the abnormal erythrocytes. Blood 1992;80(suppl 1):5a.
17. Cappellini MD, Coppola R, Bottasso B, Graziadei G, Fargion S, Mannucci PM: Hypercoagulability in patients with thalassemia intermedia. Blood 1995;86(suppl 1):643a.
18. Borenstein V, Barenholtz Y, Hy-Am E, Rachmilewitz EA, Eldor A: Phosphatidylserine in the outer leaflet of the red blood cells from beta thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes. Am J Hematol 1993;44:33-35.
19. Cappellini MD, Coppola R, Robbiolo L, Graziade G, Valentini M, Ariens RAS, Fiorelli G, Mannucci PM: Procoagulant activity of erythrocytes in thalassemia intermedia. Blood 1996; 88(suppl 1):38a.
20. Helley D, Eldor A, Girot R, Ducrocq R, Guillin MC, Bezeaud A: Comparison of the procoagulant activity of red blood cells from patients with homozygous sickle cell disease and beta thalassemia. Thromb Haemostas 1996;76: 322-327.
21. Leonardi S, Colianni R, Fischer A, Curreri R, Di Gregorio F, Pizzarelli G, Musumeci S: Serum lipids in polytransfused beta-thalassemic patients and their modifications after blood transfusion. Haematologica 1988;73:269-271.
22. Goldfarb A, Rachmilewitz EA, Eisenberg S: Abnormal low and high density lipoproteins in homozygous beta-thalassemia. Br J Haematol 1991;79:481-486.